2023 Partners
The BioArte
Innovation Partner
The BioArte, founded in 2020 by Manuele Biazzo and Christian Duchow, has created a bridge between technology and production in the field of the microbiome. The company’s most recent breakthrough led to the creation of a technology that has allowed it to dive into an even deeper analysis of the microbiota, which led to the innovative SkinDuo product.
The BioArte began by studying the human gut microbiota and has now developed a one-of-a-kind cosmetic product and others soon to come. SkinDuo directly targets the relationship of the skin-gut axis by using living bacteria and helps restore the skin’s natural barrier.
Cosmos ID
Innovation Partner
CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support.
In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision.
CosmosID-HUB, a user-friendly and interactive software for comparative analysis of microbiome data, complete with dynamic charts, visualizations, and statistics is used by researchers around the world for enabling downstream analysis & interpretation.
BLIS Technologies
Innovation Partner
Blis Technologies is a New Zealand-based developer and manufacturer of innovative probiotic solutions. Founded on the research of Professor John Tagg (University of Otago, New Zealand), the company was formed in 2000 to develop new bacterial species as probiotics for human health applications. To date, the company has developed three strains with applications for ENT/immune health (BLIS K12™), dental health (BLIS M18™) and (BLIS Q24™) for topical skin applications.
RTL Genomics & MicroGenDX
Expertise Partner
In a crowded space with many sequencing providers, RTL Genomics excels in building client relationships through our expertise to experimental design, bioinformatics, biostatistical support, and advanced consulting – even manuscript preparation and product claim development. We will facilitate your bespoke research and analysis needs.
MicroGenDX, our CAP accredited and CLIA certified parent lab, is a pioneer organization bringing microbiome applications into clinical diagnostics. Ask us about our clinical grade reference database and about how you can get more from your microbiome sequencing.
Therapeutics, Inc
ExhibitionPartner
Built upon 25 years of category-specific experience, we are dedicated to elevating the standard of dermatology drug development with clarity, collaboration and insight. Therapeutics, Inc., the dermatology CRO authority, navigates the complex maze of non-clinical, clinical and regulatory hurdles to deliver integrated, turnkey solutions built for your unique requirements, from concept to commercialization.
Human Metabolome Technologies
Exhibition Partner
Human Metabolome Technologies (HMT) is a metabolomics profiling company that specializes in pre-clinical and clinical studies. HMT provides both targeted and untargeted profiling metabolite data for a wide range of applications from any sample type. HMT enables clients to understand critical pathways for biomarker discovery, enhance drug development, perform microbiome screening and uncover mechanisms of action through profiling of over 2,000 polar metabolites using high resolution, high performance CE-MS and LC-MS solutions for hundreds of lipophilic metabolites. HMT has been building a best in class metabolite profiling program with over 17 years of service to the research and medical community.
Boston Analytical
Event Partner
Boston Analytical, the Life Sciences Division of Alpha Analytical, is a cGMP compliant, FDA/DEA registered, ISO/ IEC-17025:2005 certified analytical laboratory located in Salem, NH. We can provide all of the identity, purity and potency analyses necessary to characterize your microbiome product. Boston Analytical has a proven track record with sponsors on a variety of Microbiome programs including both Spore Fraction and Defined Drug Product manufacturing processes. We employ Labware Inc’s™ LIMS & ELN software with online data access for your convenience.